Groups
Company Size (Fulltime employees)
Looking for
Functionality
Headquartner in China
Biotech/Pharma Category
Biotech/Pharma Asset Stage
Medtech Category
Medtech Development Stage
Index
Countries
Reset

able cerebral United States

Able Cerebral is currently apply phase III clinical study with FDA for its controlled release of brain energy product. The product has shown remarkable therapeutic effectiveness for mid-stage and early stage Alzheimer's disease.

Able Cerebral is also developing a game changing, non-invasive medical device that will consolidate and recovery of brain memory for mid-stage and late stage Alzheimer's disease.

Website:
www.ablecerebral.com
Year of foundation
2012
Looking for
Funding Status
looking for investors or partners for advance our product and programs. Able Cerebral is ready to convert to Delaware C-Corp
Headquartner in China
No
Plan in China
We were planning to engage some sci-tech park in China before the pandemic.
Biotech/Pharma Category
Biotech/Pharma Asset Stage
Medtech Category
Medtech Development Stage
Slides Deck
(pptx, 308.49KB)
jun xia
Co-Founder / President 
Functionality
Management